Javascript er ikke aktivert i din nettleser. Dette er nødvendig for å bruke Oncolex. Kontakt din systemadministrator for å aktivere JavaScript.

Radiofrequency ablation of liver tumors

General

During radiofrequency ablation, the tumor is destroyed by radiofrequency energy. High-frequency alternating current (400,000 –1,250,000 Hz) is charged through the tumor via a needle electrode either by percutaneous, laparoscopic or open access, with the help of ultrasound guidance.

The needle consists of the outer part and one inner moveable part. When the inner part is pushed forward, multiple expanding metal rays come forward like an umbrella. The needle is isolated, except for the apical centimeter and the expanding rays. Current is applied to the needle from a generator. This produces high-frequency alternating current, which moves back and forth between the needle and 4 disc-shaped electrodes attached to both thighs of the patient.  When the generator is turned on, ionic agitation occurs in the tissue, as a result of the ions attempting to follow the directional changes caused by the alternating current. Frictional heat occurs close to the needle leading to necrosis of cells.  

It is assumed that all tumor tissue heated above 50–55 ºC for 5–10 minutes becomes necrotic.

Radiofrequency ablation is different from other types of tissue ablation in that the tissue around the needle warms up, not the needle itself.

Radiofrequency ablation is used as a supplement to liver resection or as primary treatment.

Indications

  • Liver tumors which are less than 4 cm in diameter.
  • Patients who either have too poor liver function or too poor general health.
  • Patients with liver metastases from colorectal cancer or neuroendocrine tumors where metastasis is limited in size and number.

Goal

  • Cure the disease
  • Palliation

Oslo University Hospital shall not be liable for any loss whether direct, indirect, incidental or consequential, arising out of access to, use of, or reliance upon any of the content on this website. Oslo University Hospital© 2017